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Available online 23 December 2015Verbal memory (VM) represents one of the most affected cognitive domains in schizophrenia. Multiple studies
have shown that schizophrenia is associated with cortical abnormalities, but it remains unclear whether these
are related to VM impairments. Considering the vast literature demonstrating the role of the frontal cortex, the
parahippocampal cortex, and the hippocampus in VM, we examined the cortical thickness/volume of these re-
gions. We used a categorical approach whereby 27 schizophrenia patients with ‘moderate to severe’ VM impair-
ments were compared to 23 patients with ‘low to mild’ VM impairments and 23 healthy controls. A series of
between-group vertex-wise GLM on cortical thickness were performed for speciﬁc regions of interest deﬁning
the parahippocampal gyrus and the frontal cortex. When compared to healthy controls, patients with ‘moderate
to severe’ VM impairments revealed signiﬁcantly thinner cortex in the left frontal lobe, and the parahippocampal
gyri. When compared to patients with ‘low to mild’ VM impairments, patients with ‘moderate to severe’ VM im-
pairments showed a trend of thinner cortex in similar regions. Virtually no differenceswere observed in the fron-
tal area of patients with ‘low tomild’ VM impairments relative to controls. No signiﬁcant group differences were
observed in the hippocampus. Our results indicate that patients with greater VM impairments demonstrate sig-
niﬁcant cortical thinning in regions known to be important in VM performance. Treating VM deﬁcits in schizo-
phrenia could have a positive effect on the brain; thus, subgroups of patients with more severe VM deﬁcits
should be a prioritized target in the development of new cognitive treatments.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Schizophrenia patients consistently display lower brain volumes
and reduced cortical thickness when compared to healthy controls
(Edgar et al., 2012; Kuperberg et al., 2003; Olabi et al., 2011; Shenton
et al., 2001; van Haren et al., 2011; Venkatasubramanian et al., 2008).
However, there is growing evidence of heterogeneity of brain structural
patterns in schizophrenia patients. That is, different subgroups of pa-
tients seem to show different degrees and extent of structural alter-
ations depending on their clinical or cognitive proﬁle (Cobia et al.,
2011; Nenadic et al., 2012, 2015).While verbalmemory (VM) is consid-
ered a core cognitive domain affected in schizophrenia (Aleman et al.,
1999; Cirillo and Seidman, 2003; Dickinson, et al., 2008; Keefe et al.,
2005; Lewis and Gonzalez-Burgos, 2006), some studies have alsoommon Pavilion, Room F-1132,
ada.
. This is an open access article underrevealed different subgroups of patients with a close to normal VM pro-
ﬁle (Brazo et al., 2013; Bruder et al., 2004; Kremen et al., 2004; Turetsky
et al., 2002). Yet, little is known about how cortical thickness is associat-
ed with the level of VM capacity in schizophrenia.
A large number of functional neuroimaging studies investigating VM
impairments in schizophrenia have linked lower performance to abnor-
mal brain activity in the medial temporal lobes (i.e. the hippocampus
and the parahippocampal gyrus (PHG)) and frontal lobes (Achim and
Lepage, 2005a; Francis et al., 2015; Haut et al., 2015; Hawco et al.,
2015; Hutcheson et al., 2015; Ragland et al., 2004, 2009; Weiss et al.,
2003). Nonetheless, it remains unclear whether VM impairments in
schizophrenia are related to cortical thinning in these regions. One cor-
relational study reported a similar positive and signiﬁcant relationship
between cortical thickness and VM capacity in these regions in schizo-
phrenia, and in healthy controls (Hartberg et al., 2010). A more recent
study failed to show any association between cortical thickness and
VM performance in schizophrenia, nor in healthy controls (Ehrlich
et al., 2012). The only positive relationshipwith VMobserved by the au-
thors pinpointed hippocampal volume in schizophrenia patients, but
not in healthy controls.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Demographic, clinical and neuropsychological data.
Controls ‘Low to mild’ VM impairments ‘Moderate to severe’ VM impairments p-value
(N = 23) (N = 23) (N = 27)
Mean SD Range Mean SD Range Mean SD Range
Age 33.26 8.17 22:50 34.57 8.7 24:50 35.85 8.66 21:50 0.49
IQ 112.50 14.21 80:133 99.43 12.53 75:116 90.19 12.80 70:120 b0.001
ISLT
Learning recall 27.27 3.13 20:31 24.67 2.96 21:33 16.75 4.02 7:24
Delayed recall 9.14 2.03 5:12 9.00 1.55 6:11 4.61 2.00 1:8
z-scores 0.00 0.92 −1.93:1.14 −0.47 0.75 −1.30:1.37 −2.85 1.00 −5.24 :−1.44 b0.001
N % N % N %
Gender 0.16
Male 15 65 13 57 22 81
Female 8 35 10 43 5 19
Parental socioeconomic status 0.15
Lower 1 4 4 20 3 14
Lower-middle 6 26 5 25 4 19
Middle 8 35 8 40 12 57
Upper-middle 4 17 1 5 2 10
Upper 4 17 2 10 0 0
Handeness category 0.28
Right 15 65 14 61 11 40
Moderately right 3 13 4 17 8 30
Ambidextrous 2 9 2 9 3 11
Moderately left 2 9 2 9 4 15
Left 1 4 1 4 1 4
Mean SD Range Mean SD Range
SANS (without attention total) 19.13 8.7 4:34 25.52 9.93 6:51 0.03
SAPS 17.13 18.05 0:60 20.15 15.85 1:53 0.63
Age of onset 21.74 4.56 15:33 24.22 7.69 14:43 0.19
Duration of illness 12.83 7.41 4:28 11.63 7.61 3:33 0.48
Medication (mg chlorpromazine) 632.63 472.13 45:1774 480.83 456.32 11:2179 0.26
Note: VM= verbal memory, ISLT = International Shopping List Task, SANS = Scale for the Assessment of Negative Symptoms, SAPS = Scale for the Assessment of Positive Symptoms.
Post-hoc Bonferroni correction (with a criteria of p b .05) was applied for IQ (each group differed from each other) and ISLT (a signiﬁcant difference existed between the patient
subgroups). Due to incomplete records, 3 patients with ‘low to mild’ VM impairments and 6 with ‘moderate to severe’ VM impairments havingmissing datapoints for parental socioeco-
nomic status.
21S. Guimond et al. / NeuroImage: Clinical 11 (2016) 20–29One possible explanation for the discrepancy in these results is
that VM performance may not be linearly related to cortical thickness;
thus using a regression approach may not be optimal. ConsideringFig. 1.Mean z-scores for cognitive domain evaluated by the Cogstate battery in the ‘moderate to
VM impairments.the inconsistency of previous ﬁndings, further investigation of
VM impairments in schizophrenia and cortical thickness are warranted,
and using a categorical approach based on a clinical threshold of VMsevere’ verbalmemory (VM) impairments group compared to the groupwith ‘low tomild’
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we investigated whether schizophrenia patients with signiﬁcant VM
impairments also have greater cortical thinning in key brain regions
associated with this cognitive function. We used a novel subgroup
approach, comparing patients with ‘moderate to severe’ VM impair-
ments to patients with ‘low to mild’ VM impairments, and a group of
healthy controls. We predicted that schizophrenia patients displaying
‘moderate to severe’ VM impairments would have thinner cortex in
the PHG and the frontal cortex, and reduced hippocampal volume
relative to patients with ‘low to mild’ VM impairments, and healthy
controls.
2. Methods
2.1. Study participants
Participants were recruited from different outpatient and inpatient
units at the Douglas Mental Health University Institute, Montreal, QC,Fig. 2. Statisticalmaps demonstrating cortical thickness differences between patients with ‘mod
parahippocampal ROIs.Canada; from external and community-based mental health clinics; and
from advertisements. Fifty patients with schizophrenia aged 21–50
were matched to 23 healthy control subjects on age, sex, handedness,
and highest parental level of education. Control subjects were recruited
through advertisements and were from socio-demographic areas similar
to patients.We excluded individuals with (1) a lifetime history of a med-
ical or neurological condition that has been shown to affect cognition,
(2) a family history of hereditary neurological disorders, (3) a diagnosis
of substance dependence (within the past three months), (4) presence
of depression or Parkinsonism, or (5) presence of metallic objects in the
body which are contraindicated for magnetic resonance imaging (MRI).
All participantswere assessedwith the EdinburghHandedness Inven-
tory (Oldﬁeld, 1971), the Hollingshead two-factor index of social position
(Hollingshead, 1965), and either the SCID-I (patient version) to conﬁrm
diagnosis for patients, or the SCID-I (non-patient version) to conﬁrm ab-
sence of any Axis I disorders in healthy controls. Patients further
underwent an exhaustive clinical assessment. Clinical symptoms were
assessed using the Scale for the Assessment of Negative Symptomserate to severe’ verbal memory (VM) impairments and healthy controls, within frontal and
Table 2
Brain regions displaying thinner cortex in the between-group comparisons.
Region Brodmann area Stereotaxic
coordinates of local
maxima (MNI space)
x y z
‘Moderate to severe’ b healthy controls
(p b 0.05, FDR corrected)
L anterior middle frontal gyrus 10 −29 58 −2
L posterior middle frontal gyrus 9 −44 16 32
L orbitofrontal gyrus 47 −48 24 −12
L inferior frontal gyrus 46/44 −51 30 16
L precentral gyrus 6 −62 5 18
L anterior parahippocampal gyrus 35 −23 −12 −35
L posterior parahippocampal gyrus 30 −8 −43 2
R anterior parahippocampal gyrus 35 17 −12 −31
‘Moderate to severe’ b ‘low to mild’
(p b 0.05, uncorrected)
L anterior inferior frontal gyrus 10 −45 49 4
L posterior inferior frontal gyrus 45/9 −57 17 23
L orbitofrontal gyrus 47 −46 24 −8
L middle frontal gyrus 46 −46 40 21
L precentral gyrus 6 −58 −1 9
L anterior parahippocampal gyrus 35 −19 −9 32
L posterior parahippocampal gyrus 30 −8 −45 2
R anterior parahippocampal gyrus 35 18 −12 −27
‘Low to mild’ b healthy controls
(p b 0.05, uncorrected)
L precentral gyrus 4 −44 −17 53
L anterior parahippocampal gyrus 28 −18 −16 −29
R posterior parahippocampal gyrus 35 18 −27 −18
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Symptoms (SAPS) (Andreasen, 1984b).Medicationhistorieswere obtain-
ed via self-report and veriﬁed when necessary with the treating psychia-
trist. Antipsychotic doses were converted to chlorpromazine equivalents
according to the literature (Jensen and Regier, 2010; Leucht et al., 2014;
Woods, 2003) to allow comparison between patient groups. The Douglas
Mental Health University Institute's Research Ethics Board approved the
study and all participants provided informed written consent.
As part of a larger neurocognitive assessment using theCogState bat-
tery for schizophrenia research (Pietrzak et al., 2009), all participants
performed the VM International Shopping List Task (ISLT). Participants
underwent 3 trials to learn a list of 16words, andwere later tested using
delayed recall. The performance of thematched control group (n= 25)
was then used as normative data to transform individual patient data
into z-scores. The average of the z-scores for the total recall of the 3
learning trials and for the delayed recall was computed and kept for fur-
ther comparison. Schizophrenia patients were subsequently classiﬁed
into two subgroups: patients with ‘moderate to severe’ VM impair-
ments (n= 27, z-score ≤−1.4), and patients with ‘low to mild’ VM im-
pairments (n = 23, z-score N−1.4), following the criteria of the
Compendium of Neuropsychological Tests (Spreen and Strauss, 1998).
Other cognitive domains were also assessed using CogState. Intellectual
quotient (IQ) was estimated in all participants using the Wechsler Ab-
breviated Scale of Intelligence (WASI) (Hays et al., 2002). The other
neurocognitive measures described above were collected and reported
for informational purposes, and to provide a complete cognitive proﬁle
of our two subgroups of patients.
2.2. Statistical analysis of demographic, clinical and neuropsychological
data
To verify that groups were matched, the two patient groups and the
control group were compared on age using one-way ANOVAs. Sex, pa-
rental SES, and handedness between-group differences were evaluated
using Kruskal–Wallis tests. To examine differences in overall cognitive
proﬁle between the two groups of patients, independent t-tests (with
Bonferroni correction) were applied to all neurocognitive domains of
the CogState battery. A one-way ANOVAwas computed to test for a dif-
ference in IQ. Finally, independent t-tests were used to compare anti-
psychotic dosages, negative and positive symptoms, age of onset, and
duration of the illness between the two groups of patients. All analyses
were conducted using SPSS version 20 (SPSS, Chicago, IL, USA) andwere
two-tailed with a critical p-value of .05.
2.3. Image acquisitions and processing
Weused a similar cortical thickness analytical procedure as reported
in previous studies (Buchy et al., 2011, 2012; Cassidy et al., 2014; Emami
et al., 2016). T1-weightedMR imageswere acquired using an 8-channel
head coil on a Siemens 3T Tim trio MRI at the Douglas Mental Health
University Institute's Brain Imaging Center in Montreal. The anatomical
scan was MPRAGE (TR = 2300 ms, TE = 2.98 ms, FOV 256 mm,
1mm× 1mm× 1mmvoxels, ﬂip angle= 9) and lasted 9min. Cortical
thickness was analyzed using the CIVET processing pipeline (version
1.1.10; Montreal Neurological Institute at McGill University, Montreal,
Quebec, Canada). T1-weighted images were registered to the ICBM152
nonlinear template with a 9-parameter linear transformation (Collins
et al., 1994). The T1s were then corrected for inhomogeneities (Sled
et al., 1998) and classiﬁed into different tissue types (Zijdenbos et al.,
2002). Deformablemodelswereused to createwhite andgraymatter sur-
faces for each hemisphere separately (Kim et al., 2005; MacDonald et al.,
2000) From these surfaces, the distance between the white and gray sur-
faces was measured (Lerch and Evans, 2005) and was subsequently
blurredusing a 20-mmsurface-baseddiffusionblurring kernel in prepara-
tion for statistical analyses (Lerch et al., 2008).2.4. Cortical thickness analyses
The bilateral PHG and bilateral frontal lobes were deﬁned as ROIs
using the cortical parcellations available in the LPBA40 atlas by using
the intersection of atlas regions and the cortical surface (Shattuck
et al., 2008). A mask was then created to exclude all other vertices
from the analyses. The RMINC package (version 1.0) was used to ana-
lyze the vertex-wise cortical thickness within the ROIs. Vertex-wise
GLMs using group membership (healthy controls, patients with ‘low
to mild’ VM impairments, and patients with ‘moderate to severe’ VM
impairments) as the independent variable, and cortical thickness as
the dependent variable, including age and sex, were then performed
at each vertex within the ROI in order to reduce the burden of multiple
comparisons, and to perform a comparison in line with our hypotheses.
Correction for multiple comparisons across all vertices included in each
ROIwas determined using the false discovery rate (FDR;Genovese et al.,
2002). Vertices surviving 5% FDR were considered statistically signiﬁ-
cant. For the ROI where a signiﬁcant between-group effect was found,
we performed the same GLM analyses, but used each pair of groups in-
dependently to investigate where these differences were. Effect sizes
were also explored using standardized beta values.
2.5. Hippocampal volumes analyses
Due to the prominent role of the hippocampus in schizophrenia
(Heckers, 2001), we also explored between-group differences in
the hippocampal volumes. Fully-automated segmentation of the hippo-
campus was carried out using theMAGeT Brain algorithm (Chakravarty
et al., 2013; Pipitone, et al., 2014; Voineskos et al., 2015; https://github.
com/CobraLab/MAGeTbrain). This modiﬁed multi-atlas segmentation
technique is designed to use a limited number of high-qualitymanually
segmented atlases of the hippocampal subﬁelds as input (Winterburn
et al., 2013; http://cobralab.ca/digital-atlases). Atlas segmentations are
propagated to a template library and then to subjects using nonlinear
registration, and a subset of the population under study is used as the
template library through which the ﬁnal segmentation is bootstrapped.
Each subject in the template library is segmented through nonlinear
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unique deﬁnitions of the hippocampus for each of the templates. In the
current study, 21 templates, a number shown to be optimal in previous
work (Pipitone et al., 2014), were used from the overall subject pool.
Ten controls and eleven patientswere chosen to ensure a representative
template set. This resulted in 105 candidate labels for each subject, and
labels were then fused using a majority vote to complete the segmenta-
tion process. Nonlinear registration was performed using a version of
the Automatic Normalization Tools (ANTS) registration technique
(Avants et al., 2008) that is compatible with the minc toolkit (https://
github.com/vfonov/mincANTS). As the dentate gyrus and subiculum
are included within the MAGeT Brain algorithm, the term “hippocam-
pus” used throughout this manuscript encompasses the hippocampal
formation. Hippocampal differences were explored using a 2 × 3
MANCOVA, with hemisphere (left and right) as a within-group factor,
groupmembership (healthy controls, patientswith ‘moderate to severe’
VM impairments, and patients with ‘low to mild’ VM impairments) as
the between-group factor, and covarying for age, sex, and total brain
volume. Exploratory MANCOVAs using the same group membershipFig. 3. Statistical maps demonstrating cortical thickness differences between patients with ‘m
impairments, within frontal and parahippocampal ROIs.as the between-group factor were also performed for each hippocampal
subﬁeld, using Bonferroni correction.
3. Results
3.1. Demographic, clinical and neuropsychological results
Demographic, clinical and neuropsychological data are presented in
Table 1. All groups were matched on demographic variables. ‘Low to
mild’ VM impaired patients did not signiﬁcantly differ on VM when
compared with healthy controls. ‘Moderate to severe’ VM impaired pa-
tients had signiﬁcantly lower verbal memory (p b .005), as well as sig-
niﬁcantly lower executive functioning (p b .05), than ‘low to mild’ VM
impaired patients, and healthy controls. Importantly, both subgroups
of patients did not signiﬁcantly differ from each other on any other cog-
nitive domain. Moreover, as illustrated by their cognitive proﬁle, repre-
sented in Fig. 1, both subgroups differ mainly on VM capacity. A
signiﬁcant difference in IQ was also present between all groups
(p b .05). Post-hoc Pearson correlations showed strong positiveoderate to severe’ verbal memory (VM) impairments and patients with ‘low to mild’ VM
25S. Guimond et al. / NeuroImage: Clinical 11 (2016) 20–29correlations between VM and executive function (r = .58, p b .0001,
R2 = .33), as well as between VM and IQ (r = .60, p b .0001, R2 =
.36). Finally, the subgroup of patients with ‘moderate to severe’ VM im-
pairments also had more severe negative symptoms (SANS total;
p b .05). All other clinical features were similar in both subgroups.
3.2. Cortical thickness results
3.2.1. Between-group comparison
The ROI vertex-wise GLM analyses showed signiﬁcant between-
group differences for the left frontal lobes (F(3, 69) =−2.77, p b .05),
and for the bilateral PHG (left: F(3, 69) = −2.60, p b .05; right:
F(3,69) = −2.81, p b .05). No signiﬁcant between-group differences
were observed in the right frontal lobe. We then performed the same
GLM analyses but used each pair of groups separately to investigate
where these differences were. Statistical cortical thickness maps
(Fig. 2) revealed signiﬁcantly thinner cortex in ‘moderate to severe’
VM impaired patients compared to healthy controls, in the left frontal
lobe (F(3, 46) =−2.86, p b .05; this included the middle frontal gyrus,Fig. 4. Statistical maps demonstrating cortical thickness differences between patients with ‘l
parahippocampal ROIs.the inferior frontal gyrus, the orbitofrontal gyrus, and the precentral
gyrus; see Table 2).We also observed signiﬁcantly thinner cortex in pa-
tients with ‘moderate to severe’ VM impairments in the bilateral PHG
when compared to healthy controls (left: F(3, 46) = −2.70, p b .05;
right: F(3, 46) =−2.94, p b .05).
As shown in Fig. 3, the comparison between both groups of patients
revealed a trend for thinner cortex in patients with ‘moderate to severe’
VM impairments in the left frontal lobe (F(3, 46) =−2.01, p b .05 uncor-
rected; this included the middle frontal gyrus, the inferior frontal gyrus,
the orbitofrontal gyrus and the precentral gyrus; see Table 2). We also
observed a trend of thinner cortex in the PHG for patients with ‘moder-
ate to severe’ VM impairments, compared to patients with ‘low to mild’
VM impairments (Left: F(3, 46) =−2.01, p b .05; right: F(3, 46) =−2.03,
p b .05).
Patients with ‘low to mild’ VM impairments compared to healthy
controls (Fig. 4) showed a trend of thinner cortex in the bilateral PHG
(left: F(3, 42) = −2.03, p b .05 uncorrected; right: F(3, 42) = −2.03,
p b .05 uncorrected), and in a negligible amount of cortex in the
precentral gyrus (F(3, 42) =−2.01, p b .05 uncorrected). Examinationow to mild’ verbal memory (VM) impairments and healthy controls, within frontal and
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ate to severe’ VM impairments patients (Figs. 2a and 3a), ‘low to mild’
VM impairments patients seem to have cortical thickness indices com-
parable to controls within the left prefrontal cortex (Fig. 4a).
Post-hocGLM(sex and age controlled) revealed no signiﬁcant differ-
ences (p b 0.05 FDR corrected) when all patients (as a single group)
were compared to the healthy controls, for any ROI.
3.3. Hippocampal volumes
As presented in Fig. 5, the 2×3 (hemisphere x group)MANCOVAdid
not reveal any signiﬁcant main effects of hemisphere (F(1, 67) = 0.08,
p= 0.78) or group (F2, 67 = 2.4, p= 0.10). No signiﬁcant interactions
were found (F(2, 67) = 1.41, p= 0.25). Exploratory investigation of the
hippocampal subﬁelds did not show any differences between the
groups after Bonferroni correction.
4. Discussion
Our ﬁndings demonstrate that schizophrenia patients with more se-
vere VM dysfunction have greater cortical thinning in key brain regions
associated with VM capacity. In the current study, we compared schizo-
phrenia patients with ‘moderate to severe’ VM impairments, to patients
with ‘low tomild’VM impairments and to healthy controls. As predicted,
we observed signiﬁcantly thinner cortex in the PHGand in the left frontal
cortex in the ‘moderate to severe’ VM impairments group when com-
pared to healthy controls, and with a more liberal threshold, when com-
pared to ‘low to mild’ VM impaired patients. More speciﬁcally, we
observed thinner cortex in the left inferior frontal gyrus, which is associ-
ated with VM performance in healthy populations (Baker et al., 2001;
Casasanto, et al., 2002), the left middle frontal gyrus, which is involved
in complex post-retrieval monitoring (Achim and Lepage, 2005b), and
theorbitofrontal cortex,whichplays a role in themobilization of efﬁcient
encoding strategies in VM (Savage et al., 2001). Abnormalities in neural
activity in relation to VM deﬁcits in schizophrenia have been previously
observed in these regions of the frontal cortex, as well as in the PHG
(Achim and Lepage, 2005a; Francis et al., 2015; Haut et al., 2014;
Hawco et al., 2015; Hutcheson et al., 2015; Ragland et al., 2004, 2009;
Weiss et al., 2003). Therefore, in addition to previous functional neuro-
imaging studies, our results strongly support the relationship betweenFig. 5. Left and right hippocampal volumes (mm3) for each gVM and structural abnormality observed in the left frontal cortex and
the PHG in schizophrenia patients.
Separating patients into two subgroups depending on their level of
VM capacity contributes to a better understanding of previous inconsis-
tent relationships reported between cortical thickness and VM in
schizophrenia. Indeed, previous studies have found opposing results re-
garding whether there is a relationship between cortical thickness and
VM in schizophrenia when compared to healthy controls (Hartberg
et al., 2010; Ehrlich et al., 2012). One possible explanation is that VM
may not be linearly related to cortical thickness. Nonetheless, our re-
sults suggest that patients who display more severe VM impairments
also have thinner cortex in key regions responsible for this cognitive do-
main. Thus, the level of VM capacity in previous studies sample may
have inﬂuenced their ﬁndings.
In the present study, we did not ﬁnd any signiﬁcant differences in
our ROIs when all patients were compared to the healthy control
group. This could be explained by the selection of our healthy controls,
who share similar socio-demographic features to that of our patient
groups. This also highlights that the sole differences surviving FDR cor-
rection were between the healthy control group and the patient group
with ‘moderate to severe’ VM deﬁcits. No signiﬁcant differences were
observed between patients with ‘low to mild’ VM impairments and
healthy controls. Even when utilizing a more liberal threshold of
p b .05 uncorrected, this group of patients showed similar cortical thick-
ness in the left prefrontal cortex when compared to healthy controls.
These results provide strong support for the work of Cobia et al.
(2011), where no signiﬁcant cortical differences were found between
their healthy control group and a cognitively intact group of schizophre-
nia patients. These results also suggest that differences in the left pre-
frontal cortex observed in previous studies comparing schizophrenia
patients with healthy controls (e.g., Kuperberg et al., 2003; van Haren
et al., 2011) could have been driven in part by the level of VM impair-
ments in patients, which many studies do not account for.
Results from the exploratory hippocampal volume analysis are not
in line with the previously reported positive relationship between this
region and VM (Gur et al., 2000; Ehrlich et al., 2012). In addition, we
only observed a trend between-group effect (p=0.10), and did not rep-
licate hippocampal volume differences between patients and healthy
controls that were previously obtained (Honea et al., 2005; Wright
et al., 2000). Nonetheless, some previous studies also failed to showroup (VM= verbal memory). Bars indicate the means.
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(Niemann et al., 2000; Sanﬁlipo et al., 2000;Walker et al., 2002). In a re-
cent review, Adriano et al. (2012) suggest that variations in image seg-
mentation techniques could explain these differences. As noted by our
group (Pipitone et al., 2014) and others (Morey et al., 2010), some seg-
mentation pipelines such as FreeSurfer may be prone to false positives
due to proportional bias in theway that large and small hippocampi vol-
umes are estimated. The novel method of using the MAGeT Brain algo-
rithm to extract hippocampal volumes, as well as the relatively small
sample size, could explain our results. However, future research should
be conducted to elucidate these inconsistencies.
Whilewe reportedmultiple cognitive and demographicmeasures to
better characterize our subgroups, it is highly unlikely that our two sub-
groups of patients differ only on their level of VM capacity. Indeed, pa-
tients with ‘moderate to severe’ VM impairments also had lower IQ
and lower executive functioning, but were similar on all other neuro-
psychological measures. IQ is known to be generally lower in schizo-
phrenia (Aylward et al., 1984; Khandaker et al., 2011) and accounts
for part of the variance in VM performance among these patients
(Kopald et al., 2012). Both IQ and executive function strongly correlated
with VM in our study, and thus might account for a part of the variance
in cortical thickness observed between our groups. Some researchers
have proposed that IQ, executive function, and VM impairments in
schizophrenia could reﬂect a common abnormality of information pro-
cessing in prefrontal cortex rather than speciﬁc deﬁcits in different cog-
nitive domains (Leeson et al., 2009). However, further studies with
greater statistical power should investigate the speciﬁc effect of cortical
thickness on VM performance in relation to other cognitive domains
known to be affected in schizophrenia.
Our two subgroups of patients were relatively similar on all other
demographic and clinical measures, with the exception of negative
symptom severity. Negative symptoms in schizophrenia are related
to VM deﬁcits (Harvey et al., 2006; Hovington et al., 2013) and as
such, this difference is not surprising. There are several studies
that have not found signiﬁcant cortical thickness associations with neg-
ative symptom severity in schizophrenia (Sigmundsson et al., 2001;
Kuperberg et al., 2003; Rimol et al., 2012; Xiao et al., 2015). However,
other volumetric studies revealed associations between persistent neg-
ative symptoms and brain volume reductions in schizophrenia, speciﬁ-
cally in the prefrontal and temporal cortices (Bodnar et al., 2014;
Hovington and Lepage, 2012; Galderisi et al., 2015). Our results add an
important contribution to previous studies that compare cortical thick-
ness between subgroups of patients based solely on clinical features,
without reporting any neurocognitive information. Recently, Nenadic
et al. (2015) reported more extensive cortical thinning within a sub-
group of schizophrenia patients who have more negative symptoms,
implicating the prefrontal cortex and the PHG. Considering the strong
associations between the two, it is possible that both VM and negative
symptoms share common neural substrates involving prefrontal and
PHG regions. Therefore, further investigation is necessary to better un-
derstand the speciﬁc and/or common effects of VM and negative symp-
toms on these areas.
Finally, our results suggest that schizophrenia patients with VM
memory deﬁcits are more likely to have thinner cortex, which may
have signiﬁcant clinical implications. VM deﬁcits are associated with
poor community functioning and poor response to psychosocial reha-
bilitation programs (Green et al., 2000; Evans et al., 2004). For example,
schizophrenia patients who demonstrate greater VM impairments also
tend to have poorer clinical and functional outcomes (Bodnar et al.,
2008; Lepage et al., 2014). Investigating the association between VM
impairments and cortical thickness in schizophrenia could provide im-
portant insights into the neuronal markers of poor clinical trajectories.
A recent study observed associations between higher social withdrawal
and reduced bilateral PHG volume in ﬁrst-episode schizophrenia
(Bodnar et al., 2012). This region is signiﬁcantly reduced in the present
study and appears to be related to both VM and clinical outcome.Further studies should explore the relationship between neural corre-
lates of VM and daily functioning. Considering the importance of VM
in a patient's global functioning and clinical outcome (Benoit et al.,
2014; Bodnar et al., 2008; Evans et al., 2004; Green et al., 2000;
Lepage et al., 2014), treatments targeting this type of memory and im-
proving neurocognition should be encouraged. Administration of cogni-
tive remediation to schizophrenia patients has shown a small to
moderate positive effect on memory (McGurk et al., 2007; Wykes
et al., 2011). Interestingly, cognitive enhancement therapy demon-
strates signiﬁcantly greater preservation of gray matter volume over
2 years in the left hippocampus, PHG, and fusiform gyrus, and signiﬁ-
cantly greater graymatter increases in the left amygdala in early schizo-
phrenia (Eack et al., 2010). Additionally, speciﬁc cognitive training
focusing on semantic encoding strategies has recently been shown to
have a positive impact on VM in chronic schizophrenia (Guimond and
Lepage, 2015). It would be of great interest to investigate towhat extent
deﬁcits in semantic encoding strategiesmay explainVM impairments in
schizophrenia, as well as related structural and functional brain abnor-
malities. Moreover, studies examining the impact of the aforemen-
tioned therapies on VM and associated brain structures at every stage
of schizophrenia (i.e. prodromal, acute, and residual) are warranted.5. Conclusion
In summary, we investigated whether schizophrenia patients with
more severe VM deﬁcits demonstrate greater cortical thinning. We ob-
served that patients with ‘moderate to severe’ VM impairments have
signiﬁcantly thinner cortex in the left frontal cortex and bilateral PHG
compared to healthy controls. Furthermore, using amore liberal thresh-
old, we observed thinner cortex in these regions in patients with ‘mod-
erate to severe’ VM impairments compared to patients with ‘low to
mild’ VM impairments. However, even given this more liberal thresh-
old, patients with ‘low tomild’ VM impairments showed similar cortical
thickness compared to healthy controls in the left prefrontal cortex.
Therefore, our results posit that a subgroup of patientswithmore severe
VM impairments show greater cortical thinning in regions previously
linked to this cognitive domain. Considering that patients with schizo-
phrenia and VM deﬁcits are more likely to have poor outcomes, gaining
a better understanding of correlated brain abnormalities of this sub-
group of patients is critical. Furthermore, our ﬁndings demonstrate
that treatments targeting VM impairments in schizophrenia are war-
ranted and should be encouraged.Role of funding
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